Autocrine Human Growth Hormone Promotes Invasive and Cancer Stem Cell-Like Behavior of Hepatocellular Carcinoma Cells by STAT3 Dependent Inhibition of CLAUDIN-1 Expression

Despite progress in diagnosis and treatment of hepatocellular carcinoma (HCC), the clinical outcome is still unsatisfactory. Increased expression of human growth hormone (hGH) in HCC has been reported and is associated with poor survival outcome in HCC patients. Herein, we investigated the mechanism of the oncogenic effects of hGH in HCC cell lines. In vitro functional assays demonstrated that forced expression of hGH in these HCC cell lines promoted cell proliferation, cell survival, anchorage-independent growth, cell migration, and invasion, as previously reported. In addition, forced expression of hGH promoted cancer stem cell (CSC)-like properties of HCC cells. The increased invasive and CSC-like properties of HCC cells with forced expression of hGH were mediated by inhibition of the expression of the tight junction component CLAUDIN-1. Consistently, depletion of CLAUDIN-1 expression increased the invasive and CSC-like properties of HCC cell lines. Moreover, forced expression of CLAUDIN-1 abrogated the acquired invasive and CSC-like properties of HCC cell lines with forced expression of hGH. We further demonstrated that forced expression of hGH inhibited CLAUDIN-1 expression in HCC cell lines via signal transducer and activator of transcription 3 (STAT3) mediated inhibition of CLAUDIN-1 transcription. Hence, we have elucidated a novel hGH-STAT3-CLAUDIN-1 axis responsible for invasive and CSC-like properties in HCC. Inhibition of hGH should be considered as a therapeutic option to hinder progression and relapse of HCC.

[1]  M. Zhang,et al.  Human growth hormone and human prolactin function as autocrine/paracrine promoters of progression of hepatocellular carcinoma , 2016, Oncotarget.

[2]  T. Zhu,et al.  Autocrine human growth hormone stimulates the tumor initiating capacity and metastasis of estrogen receptor-negative mammary carcinoma cells. , 2015, Cancer letters.

[3]  M. Zhang,et al.  Autocrine/Paracrine Human Growth Hormone-stimulated MicroRNA 96-182-183 Cluster Promotes Epithelial-Mesenchymal Transition and Invasion in Breast Cancer* , 2015, The Journal of Biological Chemistry.

[4]  Hua Yu,et al.  Revisiting STAT3 signalling in cancer: new and unexpected biological functions , 2014, Nature Reviews Cancer.

[5]  S. Pinder,et al.  Growth Hormone Is Secreted by Normal Breast Epithelium upon Progesterone Stimulation and Increases Proliferation of Stem/Progenitor Cells , 2014, Stem cell reports.

[6]  G. Yoon,et al.  Claudin-1 induces epithelial–mesenchymal transition through activation of the c-Abl-ERK signaling pathway in human liver cells , 2013, Oncogene.

[7]  W. Qin,et al.  MicroRNA‐155 is a novel suppressor of ovarian cancer‐initiating cells that targets CLDN1 , 2013, FEBS letters.

[8]  K. Mimori,et al.  Increased CD13 Expression Reduces Reactive Oxygen Species, Promoting Survival of Liver Cancer Stem Cells via an Epithelial–Mesenchymal Transition-like Phenomenon , 2012, Annals of Surgical Oncology.

[9]  Wen-bin Liu,et al.  Activation of STAT3 signal pathway correlates with twist and E-cadherin expression in hepatocellular carcinoma and their clinical significance. , 2012, The Journal of surgical research.

[10]  X. Chen,et al.  Claudin-1 up-regulates the repressor ZEB-1 to inhibit E-cadherin expression in colon cancer cells. , 2011, Gastroenterology.

[11]  J. Datta,et al.  IL-6 Promotes Head and Neck Tumor Metastasis by Inducing Epithelial–Mesenchymal Transition via the JAK-STAT3-SNAIL Signaling Pathway , 2011, Molecular Cancer Research.

[12]  W. Ding,et al.  Snail1 induces epithelial-to-mesenchymal transition and tumor initiating stem cell characteristics , 2011, BMC Cancer.

[13]  K. Turksen,et al.  Junctions gone bad: claudins and loss of the barrier in cancer. , 2011, Biochimica et biophysica acta.

[14]  I. Ng,et al.  CD24(+) liver tumor-initiating cells drive self-renewal and tumor initiation through STAT3-mediated NANOG regulation. , 2011, Cell stem cell.

[15]  Federica Madia,et al.  Growth Hormone Receptor Deficiency Is Associated with a Major Reduction in Pro-Aging Signaling, Cancer, and Diabetes in Humans , 2011, Science Translational Medicine.

[16]  Jing Jiang,et al.  Growth hormone signaling in human T47D breast cancer cells: potential role for a growth hormone receptor-prolactin receptor complex. , 2011, Molecular endocrinology.

[17]  C. Mathers,et al.  Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 , 2010, International journal of cancer.

[18]  S. Harvey.  Extrapituitary growth hormone , 2010, Endocrine.

[19]  K. Mimori,et al.  CD13 is a therapeutic target in human liver cancer stem cells. , 2010, The Journal of clinical investigation.

[20]  P. Dhawan,et al.  Claudin Family of Proteins and Cancer: An Overview , 2010, Journal of oncology.

[21]  Peter Kraft,et al.  Pathway analysis of breast cancer genome-wide association study highlights three pathways and one canonical signaling cascade. , 2010, Cancer research.

[22]  D. Lai,et al.  Characterization of primary ovarian cancer cells in different culture systems. , 2010, Oncology reports.

[23]  S. Thorgeirsson,et al.  Stem Cells in Hepatocarcinogenesis: Evidence from Genomic Data , 2010, Seminars in liver disease.

[24]  Wei Zhao,et al.  The properties of tumor-initiating cells from a hepatocellular carcinoma patient's primary and recurrent tumor. , 2010, Carcinogenesis.

[25]  Wenlin Huang,et al.  The polycomb group protein Bmi-1 represses the tumor suppressor PTEN and induces epithelial-mesenchymal transition in human nasopharyngeal epithelial cells. , 2009, The Journal of clinical investigation.

[26]  G. Yoon,et al.  Claudin-1 Acts through c-Abl-Protein Kinase Cδ (PKCδ) Signaling and Has a Causal Role in the Acquisition of Invasive Capacity in Human Liver Cells* , 2009, The Journal of Biological Chemistry.

[27]  X. Wang,et al.  EpCAM-positive hepatocellular carcinoma cells are tumor-initiating cells with stem/progenitor cell features. , 2009, Gastroenterology.

[28]  C. Print,et al.  Autocrine human growth hormone promotes tumor angiogenesis in mammary carcinoma. , 2009, Endocrinology.

[29]  G. Niu,et al.  Tumor-induced upregulation of Twist, Snail, and Slug represses the activity of the human VE-cadherin promoter. , 2009, Archives of biochemistry and biophysics.

[30]  A. Puisieux,et al.  Generation of Breast Cancer Stem Cells through Epithelial-Mesenchymal Transition , 2008, PloS one.

[31]  M. Mitchell,et al.  Autocrine human growth hormone stimulates oncogenicity of endometrial carcinoma cells. , 2008, Endocrinology.

[32]  D. Louis,et al.  Deregulation of a STAT3–Interleukin 8 Signaling Pathway Promotes Human Glioblastoma Cell Proliferation and Invasiveness , 2008, The Journal of Neuroscience.

[33]  Wenjun Guo,et al.  The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells , 2008, Cell.

[34]  C. Deng,et al.  Progenitor/stem cells give rise to liver cancer due to aberrant TGF-β and IL-6 signaling , 2008, Proceedings of the National Academy of Sciences.

[35]  Sheng-Chieh Hsu,et al.  Epidermal growth factor receptor cooperates with signal transducer and activator of transcription 3 to induce epithelial-mesenchymal transition in cancer cells via up-regulation of TWIST gene expression. , 2007, Cancer research.

[36]  Shohachi Suzuki,et al.  Loss of claudin-1 expression correlates with malignancy of hepatocellular carcinoma. , 2007, The Journal of surgical research.

[37]  P. Lobie,et al.  The oncogenic potential of growth hormone. , 2006, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.

[38]  Ronald A. DePinho,et al.  Hepatocellular carcinoma pathogenesis: from genes to environment , 2006, Nature Reviews Cancer.

[39]  Tetsuhiro Chiba,et al.  Side population purified from hepatocellular carcinoma cells harbors cancer stem cell–like properties , 2006, Hepatology.

[40]  Francesc X. Soriano,et al.  The transcription factors Slug and Snail act as repressors of Claudin-1 expression in epithelial cells. , 2006, The Biochemical journal.

[41]  S. Eschrich,et al.  Persistent Activation of Stat3 Signaling Induces Survivin Gene Expression and Confers Resistance to Apoptosis in Human Breast Cancer Cells , 2006, Clinical Cancer Research.

[42]  M. Washington,et al.  Claudin-1 regulates cellular transformation and metastatic behavior in colon cancer. , 2005, The Journal of clinical investigation.

[43]  E. Sabo,et al.  Claudin-1 is a strong prognostic indicator in stage II colonic cancer: a tissue microarray study , 2005, Modern Pathology.

[44]  Xin Chen,et al.  Claudin-10 expression level is associated with recurrence of primary hepatocellular carcinoma. , 2005, Clinical cancer research : an official journal of the American Association for Cancer Research.

[45]  P. Gluckman,et al.  Oncogenic transformation of human mammary epithelial cells by autocrine human growth hormone. , 2005, Cancer research.

[46]  P. Gluckman,et al.  Phenotypic conversion of human mammary carcinoma cells by autocrine human growth hormone. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[47]  M. Waters,et al.  The oncogenic potential of autocrine human growth hormone in breast cancer. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[48]  R. Taub.  Liver regeneration: from myth to mechanism , 2004, Nature Reviews Molecular Cell Biology.

[49]  Zhi-yuan Yu,et al.  The STAT3 DNA-binding domain mediates interaction with NF-kappaB p65 and inducible nitric oxide synthase transrepression in mesangial cells. , 2004, Journal of the American Society of Nephrology : JASN.

[50]  M. Kubbies,et al.  Reexpression of the TJ protein CLDN1 induces apoptosis in breast tumor spheroids , 2004, International journal of cancer.

[51]  R. DePinho,et al.  Differential impact of telomere dysfunction on initiation and progression of hepatocellular carcinoma. , 2003, Cancer research.

[52]  Shoichiro Tsukita,et al.  Regulation of tight junctions during the epithelium-mesenchyme transition: direct repression of the gene expression of claudins/occludin by Snail , 2003, Journal of Cell Science.

[53]  G. Dontu,et al.  In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells. , 2003, Genes & development.

[54]  Wenzheng Zhang,et al.  Signal transducers and activators of transcription 3 (STAT3) inhibits transcription of the inducible nitric oxide synthase gene by interacting with nuclear factor kappaB. , 2002, The Biochemical journal.

[55]  D. Melton,et al.  "Stemness": Transcriptional Profiling of Embryonic and Adult Stem Cells , 2002, Science.

[56]  J. Thiery.  Epithelial–mesenchymal transitions in tumour progression , 2002, Nature Reviews Cancer.

[57]  N. Drinkwater,et al.  The little mutation suppresses DEN-induced hepatocarcinogenesis in mice and abrogates genetic and hormonal modulation of susceptibility. , 2001, Carcinogenesis.

[58]  K. Snibson,et al.  Overexpressed growth hormone (GH) synergistically promotes carcinogen-initiated liver tumour growth by promoting cellular proliferation in emerging hepatocellular neoplasms in female and male GH-transgenic mice. , 2001, Liver.

[59]  S. Fan,et al.  Risk factors, prevention, and management of postoperative recurrence after resection of hepatocellular carcinoma. , 2000, Annals of surgery.

[60]  M. Chevallier,et al.  Increased expression of growth hormone and prolactin receptors in hepatocellular carcinomas , 2000, Endocrine.

[61]  F. Xy.  From PTK-STAT signaling to caspase expression and apoptosis induction. , 1999 .

[62]  J. Darnell,et al.  Stat3 as an Oncogene , 1999, Cell.

[63]  M. Brandon,et al.  High, persistent hepatocellular proliferation and apoptosis precede hepatocarcinogenesis in growth hormone transgenic mice. , 1999, Liver.

[64]  D. Leroith,et al.  Growth hormone treatment induces mammary gland hyperplasia in aging primates , 1997, Nature Medicine.

[65]  J. Darnell.  STATs and gene regulation. , 1997, Science.

[66]  A. S. Conner,et al.  Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo , 1996, The Journal of experimental medicine.

[67]  B. Groner,et al.  Participation of JAK and STAT Proteins in Growth Hormone-induced Signaling (*) , 1996, The Journal of Biological Chemistry.

[68]  J. Ripperger,et al.  Receptors for interleukin-3 (IL-3) and growth hormone mediate an IL-6-type transcriptional induction in the presence of JAK2 or STAT3. , 1995, Blood.

[69]  J. Darnell,et al.  Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. , 1994, Science.

[70]  M. Shaw,et al.  The circulating growth hormone (GH)-binding protein complex: a major constituent of plasma GH in man. , 1988, Endocrinology.

[71]  Kai Song,et al.  Dysregulation of signaling pathways and putative biomarkers in liver cancer stem cells (Review). , 2013, Oncology reports.

[72]  M. Karin,et al.  NF-κB and STAT3 – key players in liver inflammation and cancer , 2011, Cell Research.

[73]  M. Salto‐Tellez,et al.  Claudin-1 has tumor suppressive activity and is a direct target of RUNX3 in gastric epithelial cells. , 2010, Gastroenterology.

[74]  F. Casanueva,et al.  Oncological Complications of Excess GH in Acromegaly , 2004, Pituitary.

[75]  X-Y Fu.  From PTK-STAT signaling to caspase expression and apoptosis induction , 1999, Cell Death and Differentiation.

[76]  J. Schwartz,et al.  Molecular mechanism of growth hormone action. , 1996, Annual review of physiology.

[77]  R. Grün,et al.  Peptide hormones in liver cirrhosis and hepatocellular carcinoma. , 1981, Oncodevelopmental biology and medicine : the journal of the International Society for Oncodevelopmental Biology and Medicine.